Remove Drug Development Remove Immune Response Remove Molecular Biology
article thumbnail

Unlocking Undruggable Targets: Shifting Paradigms in Modern Drug Discovery

DrugBank

But as molecular biology has advanced, so too has our approach to finding new drugs. Its structure makes it incredibly difficult for drugs to bind effectively, which has stymied drug development for decades. These methods could bypass the need to directly target these proteins with traditional drugs.

article thumbnail

My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference

Alta Sciences

Milton also highlighted which assessments are optional for the development of gene therapies and how eliminating them could save sponsors time and money, while listing those that are essential to consider, including shedding, biodistribution , and cellular immune response assays and neutralizing antibody assays.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target

The Pharma Data

Chimeric PD-1 T-cells also release cytokines to further initiate immune responses to eradicate the tumor cells. The pipeline development is leveraged through the Company’s proprietary target discovery engine called “DIAMOND.” Barber also serves on Kiromic’s Scientific Advisory Board. About Longwood University.

article thumbnail

Scaling Phage Therapy

Codon

Such contaminants could have the same toxic effects as the bacterial infection, or provoke a severe immune response in the patient, and therefore the phage mixtures must go through extensive purification and testing procedures. Because frankly, do you know of anything else that can work against multiple drug-resistant bacteria?

Therapies 125